Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 4 matching records.
4 results — page 1 of 1
- Level CProspective StudyPubMed
Biodistribution of lentiviral transduced adipose-derived stem cells for "ex-vivo" regional gene therapy for bone repair.
Prospective Study, published in Gene Ther (2023) — summary generated from the PubMed abstract.
- 2023
Gene Ther5 citations - Level DAnimal StudyEurope PMC
Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells
Animal Study, published in Hum Gene Ther (2019) — summary generated from the PubMed abstract.
- 2019
Hum Gene Ther15 citations - Level DAnimal StudyPubMed
Genetically Engineered Adipose Mesenchymal Stem Cells Using HIV-Based Lentiviral Vectors as Gene Therapy for Autoimmune Diseases.
Animal Study on Immune Modulation, Autoimmune Research, published in Cell Reprogram (2018) — summary generated from the PubMed abstract.
- 2018
Cell Reprogram10 citations - Level DLaboratory StudyPubMed
Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases.
Laboratory Study on Autoimmune Research, published in Cell J (2014) — summary generated from the PubMed abstract.
- 2014
Cell J8 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406